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The Ethics of Control
R. Alta Charo, J.D.*'
In the beginning, there was the stem cell. While newspapers have
primarily focused on this solitary cell, caught in a swirling debate about
medical potential and research funding, others have come to recognize the
larger struggle at hand-a struggle over the control of reproduction and
human biological materials. Indeed, only days after the Bush
Administration announced its support for limited federal funding for
research on embryonic stem cells, legislators in Wisconsin, the epicenter of
embryonic stem cell research, announced their intention to introduce
legislation that looks more broadly at the infertility services that have led to
the glut of "surplus" embryos destined for destruction and eyed with
interest by stem cell researchers.' And less than three months later, some
U.S. senators found themselves trading their desire to increase federal
embryonic stem cell funding for a withdrawal of a bill to criminalize
reproductive and research cloning. This deal, however, was threatened
when a Massachusetts company announced partial success at generating
human embryos through cloning,3 triggering renewed calls for Senate
action to ban research cloning. But if this debate is less about the ethics
of research on stem cells and more about the ethics of the reproductive
control that, among other things, yields the embryos from which the stem
cells are obtained, then how can one understand the forces that shape
public attitudes?
Toward the end of Simon Mawer's novel, Mendel's Dwarf, the
protagonist, a hereditary dwarf, faces a choice: "Benedict Lambert is sitting
in his laboratory playing God. He has eight embryos in eight little tubes.
Four of the embryos are proto-Benedicts, proto-dwarfs; the other four are,
for want of a better word, normal. How should he choose?"3 How indeed?
How should he decide which of the embryos to use to make his child?
* R. AMta Charo is Professor of Law and Bioethics at the University of Wisconsin, with joint
appointments to the Law School and the Medical School's Department of Medical History
and Bioethics. From 1996-2001, she was a member of President Clinton's National
Bioethics Advisory Commission. The opinions expressed herein are her own and do not
necessarily reflect those of the Commission.
t An earlier, unannotated version of this piece appeared as R. Alta Charo, Are We Playing
God? Or Playing Human ?, WASH. POST, Aug. 12, 2001, at B1.
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Whether in the debates over human reproduction or over embryonic stem
cell research, again and again the public debates whether it is wrong to
"play God., 6 But what does this mean? If a couple decides to destroy one
of its embryos, would that be playing God? Or if a cell taken from the
inside of the mouth is cloned to make an embryo for research use, is that
crossing the line?
President Bush seems to draw that line somewhere in between. On
August 9, 2001, he endorsed federal funding for research on stem cells
derived from embryos that are now long dead, but said he would not
endorse government-financed research on cells derived from embryos yet
to be killed or those made specially for research purposes.' Citing his own
prayer and reflection, as well as America's diversity of faith, he said,
"Human life is a sacred gift from our creator," and "[w]e recoil at the idea
of... creating life for our convenience."8 These conclusions led him to a
compromise, he said, one that limits the government's entanglement with
acts that involve creating embryos but permits it to benefit from destroying
them, at least if that act of destruction happened some time ago and is
beyond our-and God's-ability to alter.9
In a country pledged from its formation not to endorse a single faith, a
country in which the decennial census shows ever-increasing diversity of
faiths-and lack of faith-in the population, how can people reach a
consensus about government policies on stem cell research while differing
on views as fundamental as whether it is righteous duty, heretical defiance,
or mere scientific inevitability to exercise control over things as
fundamental as life and death?"
The President would seem to view control over creation and
destruction of an embryo as an unacceptable act of human hubris, a view
shared by many Christian theologians. During a 1997 consideration of
cloning policy, for example, the National Bioethics Advisory Commission
(NBAC) heard similar testimony. Its members listened as theologian Dr.
Gilbert Meilaender testified that Protestants, although stout defenders of
human freedom, nonetheless "have not located the dignity of human
beings in a self-modifying freedom that knows no limit, [not]
even.. .God."" Rev. Albert Moraczewski, a Catholic, testified that cloning
"exceed[s] the.. .delegated dominion given to the human race. There is no
evidence that humans were given the power [by God] to alter their nature
or the manner in which they come into existence."2
So what should Benedict do? Should he refuse to choose, because
choosing is an act of God, an act that exceeds his delegated dominion over
life? Benedict's instinct about God's role is in fact somewhat different:
Of course we all know that God has opted for the easy way out. He has
11:1 (2001)
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decided on chance....You may.. .select two of the four normal embryos
and send them over to the clinic for implantation.. .or... select the four
achondroplastics, the four stunted little beings... and send them over
instead...or... refuse to usurp the powers of God and choose instead to
become as helpless as He...by choosing one normal embryo and one
achondroplastic and leaving the result to blind and careless chance.
13
When fertile couples have intercourse, sometimes an egg is fertilized.
At times, the uterine lining catches that fertilized egg, and it develops into
a baby. At other times the fertilized egg slides past that lining and is
washed away in menstrual blood, unnoticed and unmourned at the end of
the month. Should infertile couples whose embryos rest in laboratory
dishes rather than the womb be similarly careless, rolling dice to decide
whether to use or destroy them? Or are they--as is our government-
obliged to take control and ensure that each and every embryo is placed in
the body at just the right time to maximize the chance of gestation and
beat the natural odds? If the latter, then, should this action, this defiance
of the natural order of chance and luck, also suggest the option to choose
not to use the embryo, but instead to donate it for potentially life-saving
research?
It is evident that Americans do not share a common view on the act of
choice where creating life is concerned, and that is why the stem cell issue
is so difficult. While some see choosing as "playing God,"14 others see it as
"playing human."' 5 Indeed, Rabbi Elliot Dorff testified at that same NBAC
meeting that we are "the partner of God in the ongoing act of creation. We
are God's agent .... The [Jewish] tradition has not been passive in terms of
simply accepting whatever medical cards we have been dealt.' 6 Examining
Biblical texts, Rabbi Moshe Tendler testified that being such a partner
means taking an active role, and that "artificiality," far from being wrong or
evil, is rather a sign of humanity's constructive contribution, a sign that we
are doing our duty.'7 Furthermore, a professor of Islamic studies, Aziz
Sachedina, described how the Koran suggests that "as participants in the
act of creating with God, God being the best of creators, human beings can
actively engage in furthering the overall state of humanity by intervening
in the works of nature, including the early stages of embryonic
development" when the goal is to achieve a natural good, such as health or
fertility.
8
For those who view acts of reproductive control as heretical, it is
difficult to tolerate the waste that accompanies modern infertility care, its
laboratories filled with frozen surplus embryos that are no longer wanted
by anyone. But it becomes almost insurmountably galling to them to be
asked to pay for research using stem cells derived from some of these
3
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embryos, even if the embryos would have been destroyed anyway, and even
if their tax dollars will not be used in any way to help or hasten that
destruction. For many opponents of stem cell research, publicly funded
research makes every taxpayer unwillingly complicit in the underlying,
immoral choice to destroy the embryo.' 9 It matters not that most would
not hesitate to accept organ donation from the victim of a carjacking and
murder; while they might mourn the necessity of finding their own lives
saved through the death of another, in no way would they feel that their
acceptance of this gift of life made them complicit in the underlying
brutality of the victim's death.
Where embryonic stem cells are concerned, however, the sense of
complicity persists. Perhaps it is because the embryos, while already
doomed, are viable until their stem cells are removed, raising images of
state-sanctioned execution by disembowelment. Or perhaps it is simply
because opponents fear becoming complicit, not in the act of embryonic
destruction itself, but in a culture of tolerance for embryonic destruction, a
culture that might become increasingly comfortable with balancing the
needs of the born against the needs of the embryo, a culture that balances
not only the needs of patients against embryonic loss, but also the needs of
scared teenagers or impoverished women with unwelcome pregnancies.
There are, of course, broader implications of the President's decision.
He cited not only the diversity of faiths in the United States and the
diversity of opinions within those faiths, but also the diversity of experience
in this country with the illnesses that might best be cured by research with
embryonic stem cells. "I have friends whose children suffer from juvenile
diabetes," Bush said. "Nancy Reagan has written me about President
Reagan's struggle with Alzheimer's. My own family has confronted the
tragedy of childhood leukemia."° This visceral, intimate knowledge of the
interests held in the balance led him to approve limited funding because
of the responsibility, in his words, to juxtapose "the need to protect life in
all its phases with the prospect of saving and improving life in all its stages."
Should this not lead him to consider, then, whether other people's
visceral, intimate knowledge of the ravages of birth defects, unwanted
pregnancy, or infertility makes an equally compelling case for tolerating
embryonic loss and enhanced reproductive control? Indeed, does his
decision not commit him to a position long considered pro-choice: that
the needs of those already born must be balanced against our regard for
embryonic and fetal life, and that the people entitled to decide what
happens to an embryo are not those in government but those whose
gametes were used to create it?2'
Philosopher Thomas Nagel wrote that "Morality's ambition is, or at
11:1 (2001)
4
Yale Journal of Health Policy, Law, and Ethics, Vol. 2 [2002], Iss. 1, Art. 7
https://digitalcommons.law.yale.edu/yjhple/vol2/iss1/7
CASE STUDY--CHARO
least ought to be, to provide a system of conduct under which everyone can
live with a sense of mutual justifiability. This follows from the conditions of
political legitimacy."2 A democracy consists of more than voting once a
year. It consists of ensuring that all those voters and their elected
representatives identify with both the peril and potential of each policy
choice. This is why there is hope to be found in the extended public
deliberation on embryo and stem cell research. Even its opponents will
partake in the cures that may be found for juvenile diabetes, Alzheimer's
disease, Parkinson's disease, heart disease, and spinal cord injuries. Few,
one suspects, would pledge to forever forego such treatments because of
their origins.3 The medical treatments they may receive will likely not be
sufficient to overcome their personal objections, but it does ensure that
they will not be politically insulted solely on behalf of the interests of
others; their interests, too, are promoted by this research.
This concern about the distribution of burdens and benefits of policy
choices represents something larger than the more narrowly focused
debates about the morality of stem cell research, abortion, euthanasia, or
any number of divisive practices. It is an indication that Americans are
united more by a shared desire for fair governance than divided by
respective disappointments in the particular stem cell research policy
adopted through that governance. And it is a sign that the policy choices
created by advances in the biomedical sciences may be resolved by
supplementing attention to traditional bioethics with some attention to
political ethics and a philosophy of governance that insists upon leaving no
one social group with the burdens but not the benefits of a policy choice,
and no one political movement with the desire but not the political access
to alter it.
24
In many ways, the compromise crafted by the Bush administration
concerning stem cell funding features these characteristics of political
legitimacy. By limiting funding to existing cell lines derived from long-
dead embryos,25 the arguments about complicity are moved away from
images of the executioner and toward the images of organ donation.26
Funding also enables research on alternative, less controversial forms of
stem cells, so that parallel experimentation ensures that if other sources
27ever become an adequate substitute, research on embryonic sources can
be forgone and gratuitous offense avoided. 2 At the same time, its
insistence on using only a limited number of cell lines29 (a limit that many
scientists fear will delay research that might otherwise save the lives of
people already sick today30 ) may not be supportable in the long run,3
premised as it is on a particularly personal vision of the role of humanity
and of God.
5
Charo: The Ethics of Control
Published by Yale Law School Legal Scholarship Repository, 2002
YALE JOURNAL OF HEALTH POLICY, LAW, AND ETHICS
The furor over embryonic stem cell research, in general, and research
on cloning in particular, puts one in mind of earlier conflicts between the
needs of science and the sanctity of the body-dead, alive, or yet to be
conceived. Although physicians in ancient Greece were permitted to
dissect the bodies of foreigners, dissection of Greeks was unthinkable.
Indeed, for most of the medieval era in Europe, dissections were forbidden
because of the Church's view that the human body was God's province. It
was not until the thirteenth century that strictly limited and controlled
dissection was permitted at universities, and even then the practice
continued to represent an uneasy truce between cultural taboos and
scientific advances.3
Each generation debates the limits of what can be done to the human
body and reaches its own conclusions. 34 And in every era, some scientist
feels compelled to test those limits in the name of knowledge. In the
current era, that debate will continue under the auspices of yet another
federal body set up to consider the perils and potentials of biomedical
advances-the President's Council on Bioethics, which Bush announced
on August 9th.3 ' Its chairman, Leon R. Kass of the University of Chicago,
has made his views on research cloning for stem cell retrieval rather clear.
Within days of the announcement that human embryos had been cloned
for this purpose, speaking on a national news program, he said:
The Congress of the United States by a margin of over 100 votes,
including 60 Democrats, enacted legislation [sic]3 designed to stop all
human cloning from the very start. Here we have a group of
entrepreneurs who, for their own good reasons and confident that their
good intentions are sufficient unto the day, crossed this line in defiance
of all of these things. I don't think that's the right way for us to proceed. 7
He has also said that the mandate of the President's Council on
Bioethics will go beyond merely monitoring stem cell research and will
extend to a comprehensive public discussion of how to embrace the
promise of biomedical advances without losing sight of "human decency,
human dignity, and respect for life. '8 Concerns, however, have already
been expressed about what meaning the new Council's chair will attribute
to this phrase, as his previous writings have consistently expressed
skepticism about the wisdom of things as varied as in vitro fertilization,
autopsies, and the feminist movement.39 Those concerns have mounted
with the appointment of Dean Clancy, a conservative policy aide to Rep.
Dick Armey, as the new executive director.4° Clancy is known not only for
his opposition to constitutional protection for abortion rights,"' but also for
advocating, amongst other things, a repeal of the Seventeenth
11:1 (2001)
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Amendment, 42 which provides for the direct election of United States
Senators, and for the elimination of all public funding for schools.3
John Adams once wrote, "This country has done much, I wish it may
do more, and annul every narrow idea in religion, government and
commerce."44 The President and the chair of the new Council on Bioethics
are surely, like all Americans, entitled to their personal faith and vision.
But should the day come when that vision is shown to be too narrow to
accommodate the needs of research on behalf of all Americans,45 one
hopes that the vision may broaden to encompass the diversity of all human
experience and all human faiths. One hopes that government policies will
continue to evolve to protect the interests of all citizens.
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